New dementia study reveals unexpected medication link to better brain health

Key Points:

• A new study published in Neurology suggests a link between longer estrogen exposure—through reproductive lifespan, oral contraceptives, and menopausal hormone therapy (MHT)—and healthier brain vessels in women, potentially influencing Alzheimer's disease risk.
• The research, involving 352 women around age 70, found associations between longer reproductive lifespan and fewer signs of small vessel brain damage, as well as stronger brain region connectivity among oral contraceptive and MHT users.
• Alzheimer's Research UK highlights that while these findings are intriguing, the observational nature of the study means causation cannot be confirmed, and more research is needed to understand the implications for women's brain health and dementia risk.
• Experts advise women not to alter contraceptive or hormone therapy use based on this study alone and recommend making hormonal treatment decisions with healthcare professionals tailored to individual health needs.
• The study emphasizes the potential role of estrogen in protecting brain health but calls for further investigation into how hormonal exposure impacts cognitive function and dementia development.